Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL21854752

O=C(NCc1ccccc1)[C@@H]1CNCCN1C(=O)OCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 4/20 0.46
F9 P00740 1/20 0.46
F10 P00742 1/20 0.46
F12 P00748 1/20 0.46
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
F7 P08709 1/20 0.46
PRSS3 P35030 1/20 0.46
KMT2A Q03164 1/20 0.45
HDAC1 Q13547 1/20 0.45
HTR2C P28335 1/20 0.45
MC4R P32245 1/20 0.44
CTRB1 P17538 1/20 0.44
FKBP1A P62942 1/20 0.44
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
RAB9A P51151 1/20 0.43
PDK1 Q15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL21854853 0.92 HTR2C (0.47) F2F9F10F12PRSS1
Trifluoroacetic Acid SCHEMBL21854670 0.88 KDM4E (0.52) F10KMT2AHTR2CCTRB1TSHR
Trifluoroacetic Acid SCHEMBL21854716 0.86 CTRB1 (0.52) KMT2AHTR2CCTRB1TSHRPDK1
SCHEMBL2439873 0.86 TSHR (0.48) KMT2AHDAC1HTR2CMC4RCTRB1
SCHEMBL2439870 0.86 TSHR (0.48) KMT2AHDAC1HTR2CMC4RCTRB1
Trifluoroacetic Acid SCHEMBL28969098 0.86 PRCP (0.61) F2F9F10F12PRSS1
Trifluoroacetic Acid SCHEMBL30253251 0.86 HTR2C (0.46) KMT2AHTR2CCTRB1FKBP1ATSHR
SCHEMBL1257136 0.82 HTR2C (0.50) KMT2AHTR2CCTRB1CYP3A4MAPT
SCHEMBL21854732 0.82 HTR2C (0.51) KMT2AHTR2CCTRB1TSHRRAB9A
SCHEMBL8707997 0.81 NPSR1 (0.49) KMT2AHTR2CCTRB1FKBP1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081917-A1 ΒETA-CATENIN AND B-CELL LYMPHOMA 9 (BCL9) INHIBITORS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2020-04-23 WO disclosed